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Abstract Proton magnetic resonance imaging (MRI) has
recently emerged as a clinical tool to image the lungs. This
paper outlines the current technical aspects of MRI pulse
sequences, radiofrequency (RF) coils and MRI system
requirements needed for imaging the pulmonary parenchy-
ma and vasculature. Lung MRI techniques are presented as a
“technical toolkit”, from which MR protocols will be com-
posed in the subsequent papers for comprehensive imaging
of lung disease and function (parts 2 and 3). This paper is
pitched at MR scientists, technicians and radiologists who
are interested in understanding and establishing lung MRI
methods. Images from a 1.5 T scanner are used for illustra-
tion of the sequences and methods that are highlighted.
Main Messages
• Outline of the hardware and pulse sequence requirements
for proton lung MRI
• Overview of pulse sequences for lung parenchyma, vascu-
lar and functional imaging with protons
• Demonstration of the pulse-sequence building blocks for
clinical lung MRI protocols
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Introduction
Proton magnetic resonance imaging (MRI) has recently
emerged as a clinical tool to image the lungs. This paper
outlines the current technical aspects of MRI pulse sequen-
ces, radiofrequency (RF) coils and MRI system require-
ments needed for imaging the pulmonary parenchyma and
vasculature. Lung MRI techniques are presented as a “tech-
nical toolkit”, from which MR protocols will be composed
in the subsequent papers for comprehensive imaging of lung
disease and function [1, 2].
This paper is pitched at MR scientists, technicians and
radiologists who are interested in understanding and estab-
lishing lung MRI methods.
Images from 1.5 T and 3 T clinical scanners are used for
illustration of the sequences and methods that are highlighted.
This paper does not cover the methodology for hyperpolarised
gas MRI of the lungs. Although highly attractive for the
possibility of studying physiological processes such as lung
ventilation, this technique requires sophisticated polarisation
and multinuclear RF hardware, which is currently of limited
access in routine clinical practice.
Physical lung properties relevant to MRI
The physical properties of lung parenchyma are very different
from those of tissue such as liver or brain. For MRI of the
lung, two of these tissue properties are of highest importance:
the low density and the susceptibility differences between
tissue and air.
In healthy lungs the tissue density is 0.1 g/cm3, which is
about tenfold lower than in other tissues. As the MR signal
is directly proportional to the tissue proton density, even
under perfect imaging conditions (i.e. neglecting relaxation
effects), the MR signal of the lung is ten-times weaker than
that of adjacent tissues. The low signal-to-noise ratio (SNR)
makes structural proton MRI of the lung microstructure
challenging: to increase the SNR, signal averaging can be
employed, but this increases the image acquisition times
beyond 10 min per data set, which would make the proto-
cols unsuitable for clinical routine. SNR can be increased
with larger voxel sizes; however, smaller lesions such as
peripheral lung metastases might not be visible due to partial
volume effects.
Oxygen in air is paramagnetic and tissue is diamagnetic,
which leads to a bulk magnetic susceptibility difference (Δχ0
8 ppm) at lung–air interfaces. At each tissue interface the
susceptibility difference forms a static local field gradient.
The multiple microscopic surfaces presented by the airways
and alveoli in the lungs thus create highly inhomogeneous
local magnetic field gradients on a spatial scale smaller than
the size of a typical imaging voxel (2–5 mm). These micro-
scopic field gradients lead to a rapid dephasing in gradient
echo imaging; this signal decay is typically described by an
apparent transverse relaxation time T2*, which can be as short
as 2 ms or less at B001.5 T. Thus, gradient echo MRI of lung
parenchyma becomes highly challenging and requires pulse
sequences with short echo times (TE<1–2 ms).
As the magnetic field inhomogoneity increases with B0,
even shorter T2* of about 0.5 ms are found at 3 T1. The
expected SNR gain of 3 Tover 1.5 T can often not be realised,
because it requires that TE is shortened accordingly. With
identical pulse sequences, a shorter TE can only be achieved
if more powerful gradient systems are used, but current 3 T
MR systems often utilise the same gradient units as high-end
1.5 T systems (Fig. 1).
Low-field MRI at B000.5 T or less has some potential
advantages for lung MRI with respect to the magnetic inho-
mogeneity [3], and promising results have been demonstrated
Fig. 1 1.5 T vs 3 T anatomical
image SSFSE, bSSFP and
SPGR
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with low-field MRI as a non-ionising alternative to chest X-
ray [4]. Low field strength does however require signal aver-
aging to recover signal to noise, leading to longer imaging
times, which is less attractive from a clinical perspective. The
methods in this paper are focused on implementation at 1.5 T,
as it represents a readily achievable optimal field strength for
lung MRI.
Most of the methods outlined here involve imaging during
a breath-hold of typically less than 20 s duration. Breath-hold
is achieved either in end-expiration or in full inspiration. The
state of lung inflation plays a role, in that the signal intensity
from the lung parenchyma is higher at expiration. During
expiration the relative density of protons in a voxel of paren-
chyma is increased, and the bulk volume magnetic suscepti-
bility difference is reduced as air is expelled. If, on the other
hand, high contrast to noise between the pulmonary vessels or
nodules is sought, imaging at full inspiration can provide a
darker background (Fig. 2).
Respiratory motion
In order to reliably acquire images at defined stages during
respiration (e.g. in full inspiration), respiratory or spiromet-
ric triggering and gating can be used. Synchronisation of the
image acquisition to the respiratory cycle requires the ac-
quisition of a signal that is proportional to the respiratory
state of the lung; in MRI this is achieved using either
external hardware or the MR signal of the lung itself. The
MR manufacturers often provide pneumatic bellows for this
purpose, however, MR compatible pneumotachographs
have also been used [5].
Alternatively, so-called navigator echoes can be applied
to measure the breathing motion directly via MRI. Here,
either a dedicated 90-180° spin echo excitation or a pencil
beam readout is used to measure the MR signal orthogonal
to the base of the diaphragm. A sub-second self-navigator
scan can also be integrated into the imaging sequence [7] to
provide the motion information. Thus, the motion of the
diaphragm is detected and can be used for retrospective gating
of scans during the free-breathing cycle [6]. A navigator signal
can also be extracted from free-breathing non-gated two-
dimensional (2D) lung images as long as the acquisition time
is fast compared with the motion of the diaphragm.
Pulse sequences
Modern MR systems are equipped with gradient systems
that offer a gradient strength of 40 mT/m or more with slew
rates of more than 200 mT/m/ms; thus, for a typical spatial
resolution of 1–3 mm, very short echo times of TE<1.5 ms
can be realised with gradient echo sequences. At 1.5 T it is
possible to acquire images that highlight regional fibrosis
and parenchymal density. There are three basic sequences
that have been found to be very effective for lung imaging.
All share the common features of short TEs and short
acquisition time needed when imaging the lungs and all
can benefit from the judicious use of parallel imaging [8].
They can be used with or without respiratory gating, so that
application during free-breathing or breath-hold is possible.
Spoiled gradient echo (FLASH, SPGR, FFE)
The spoiled gradient echo sequence is conceptually the
simplest imaging pulse sequence, and has been proven to
be very robust in clinical practice. Essentially, the sequence
acquires a gradient echo after RF excitation with a low flip
angle RF pulse (α<90°), and destroys the remaining mag-
netisation after the data acquisition (spoiling). The sequence
is inherently T2*-weighted, and depending on TR and α
either an additional spin density weighting or a T1-
weighting can be achieved. As lung T2* values are short,
a TE of 1 ms or less needs to be used to detect signal from
lung parenchyma; furthermore, very low flip angles of α<
10° need to be applied to minimise T1 weighting due to the
relatively long T1 of lung parenchyma (1,300 ms at 1.5 T).
Use of an asymmetric echo (~30%) and partial Fourier
reconstruction in the frequency encoding direction with a
high bandwidth > 60 kHz ensure TEs ≤ 1 ms can be met.
The sequence has multiple applications in lung MRI; for
anatomical imaging, it can be used for 2D and 3D acquisitions
with or without fat suppression. Non-contrast-enhanced
images are preferably acquired without fat suppression to
facilitate the detection of lymph nodes surrounded by medi-
astinal fat. After injection of a T1-shortening contrast agent
(e.g. Gd-DTPA) and with application of fat suppression,
lymph nodes are emphasised within the suppressed back-
ground of the mediastinal fat [9].
Combination of the gradient echo sequence with parallel
imaging methods and/or slice interpolation techniques (e.g.
Fig. 2 Balanced steady state free precession (bSSFP) images at full
inspiration and full expiration
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VIBE), enable full lung volume coverage with slices of
5 mm within short acquisition times of a breath-hold. Dy-
namic repetitive acquisitions at low resolution provide a
robust means of assessment of lung wall motion for inves-
tigation of dynamic lung volumes [10], tumour motion for
radiotherapy planning [11] and paradoxical diaphragmatic
motion.
A heavily T1-weighted 3D spoiled gradient echo se-
quence with short TR and high α is the starting point for
any contrast-enhanced structural imaging in the lung, with
high flip angles an excellent suppression of non-enhancing
anatomical regions can be achieved. Sequence parameters
for pulmonary MR angiography and perfusion imaging will
be dealt with in the section on contrast enhancement.
Balanced steady state free precession
(bSSFP—TrueFISP, FIESTA, BFE)
The bSSFP sequence is structurally very similar to the
spoiled gradient echo sequence; however, as it does not
spoil but instead re-focuses the transverse magnetisation at
the end of each TR interval, it makes more efficient use of
the available magnetisation. Within each TR all gradient
dephasing is refocused (balanced), and by using RF pulses
with alternating phases (i.e. the magnetisation is flipped
back and forth), a highly coherent steady state can be
achieved. Compared with the spoiled gradient echo se-
quence, the propagation of transverse coherence leads to a
more complex contrast behaviour, and for short TR the
contrast is proportional to the ratio T2/T1. Balanced SSFP
sequences use higher flip angles (about 70°), which lead to a
stronger signal, but also to higher specific absorption rate
(SAR) values. Balanced SSFP sequences are susceptible to
off-resonance and field inhomogeneities, which is mani-
fested as so-called banding artefacts where one to several
dark bands occur.
The fast bSSFP sequence has found many applications, in
particular in cardiac MRI, but it can also be applied to
anatomical lung imaging [12]. The similarity of the bSSFP
sequence to the spoiled gradient echo sequence also means
that short TE and TR can be realised so that it is well
adapted for rapid imaging within the time window of a
breath-hold. High readout bandwidths of 100 kHz are typ-
ically used to maximise magnetisation recycling and to
minimise TR, which reduces the size of the off-resonance
banding artefacts. The inherent T2/T1 contrast of the se-
quence [13] makes it highly effective for imaging blood and
mucus with their long T2 when compared with tissue. Fur-
thermore, a multi-slice or 3D bSSFP protocol can be used as
a quick and contrast-free means of generating a pulmonary
angiogram [14].
Single-shot fast spin echo (RARE/HASTE, Turbo FSE)
The single-shot fast spin echo sequence (SSFSE) or RARE
sequence [15] uses spin echoes (compared with FLASH and
bSSFP, which utilise gradient echoes) and is thus conceptu-
ally different from the previous imaging sequences. To
make the spin-echo acquisition suitable for rapid imaging,
a train of spin echoes is created by repeated refocusing of
the first spin echo. Thus, all lines in k-space are acquired in
a single echo train.
The SSFSE sequence is advantageous for lung imaging
as the train of 180° pulses refocuses any field inhomogene-
ity so that the images become T2-weighted. The degree of
T2-weighting is determined by the echo time of the central
k-space line (effective TE), which can be adjusted through
the choice of different k-space sampling patterns (Fig. 3).
Echo times of the order of the T2 of lung parenchyma
(about 40 ms at 1.5 T) are still suitable for lung imaging.
Compared with the sub-millisecond echo times needed for
the gradient echo sequences such a longer TE is easier to
realise; however, with an inter-echo spacing of about 4 ms, a
typical echo train for an image with 192 phase encoding
Fig. 3 T2 filter for SSFSE
Fig. 4 Body coil vs array coil
348 Insights Imaging (2012) 3:345–353
steps still amounts to 192×4 ms0768 ms. In the later echoes
of this echo train, the T2 decay will lead to significant signal
reductions. The T2 decay in the PE direction also leads to a
filter effect in k-space that manifests as blurring in the
images. Thus, it is advantageous to reduce the number of
measured k-space lines, which can effectively be achieved
by combinations of half-Fourier encoding, rectangular FOV
selection (e.g. in axial orientation, PE is chosen in anterior-
posterior direction) and parallel imaging.
The large number of 180° pulses in the SSFSE echo train
also leads to high amounts of energy deposition (high SAR
levels), which make the use of SSFSE at 3 T difficult, as
SAR increases with the square of the field strength.
Another option to reduce signal blurring in the PE direc-
tion is the segmentation of k-space. Therefore, not all k-
space lines are acquired in one echo train, but only a fraction
N is sampled, and the acquisition is repeated N times to
cover the complete k-space. Segmentation significantly pro-
longs the acquisition time, but is often required when a
spatial resolution of 1 mm or better is needed or
respiratory-triggered acquisition is needed for uncooperative
patients.
The SSFSE sequence can be combined with magnetisa-
tion preparation modules such as fat saturation, inversion
recovery preparation or even diffusion weighting to impart
additional contrast weighting to the images.
RF coils and parallel imaging
At a field strength of 1.5 T, the MR system’s body coil
provides a relatively homogeneous transmit field, delivering
a uniform flip angle over the FOV of the lung. At 3 T, flip
angles in the thorax are no longer homogeneous, which is a
consequence of the shorter RF wavelength. In principle, the
body coil can be used as a receive coil for lung imaging, but
a significantly higher SNR is achieved with a local receive
coil array that is optimised for MRI of the thorax (Fig. 4).
Typically, thoracic MR coils consist of an anterior flexible
part and a posterior part that is embedded in the patient
table. Depending on the number of available receiver chan-
nels, the coil arrays consist of 2–16 coil elements each.
Elements are arranged in rows and columns to be able to
accelerate the image acquisition in all directions using par-
allel imaging.
Parallel imaging methods [8, 16] exploit the spatial
sensitivity patterns of an array of coils to accelerate the
image acquisition by factor R. Essentially, every coil in
the array has an intrinsic spatial encoding of the MR
signal, if the sensitivities of the coil elements are spa-
tially discrete. Parallel imaging is useful in lung MRI,
where faster acquisition times can reduce breath-hold
durations and increase temporal resolution in time-
resolved contrast studies. Parallel imaging is particularly
useful in SSFSE imaging, as it shortens the echo train
length [17] and the associated k-space filter thus reduc-
ing blurring (Fig. 5). At 3 T, parallel imaging can help
reduce SAR of a SSFSE sequence, which can also
allow a shorter echo time [18].
Parallel imaging should however be used carefully, be-
cause the acceleration achieved with parallel imaging comes
at the price of a reduced SNR: an R-fold faster acquisition
lowers the SNR by √R and g-factor noise amplification
further reduces SNR in a spatially varying manner. As lung
parenchyma SNR is intrinsically low, high acceleration fac-
tors of R>4 as used in cardiac imaging are not achievable in
lung imaging. As such, coils with a large number of ele-
ments are not essential for the parallel imaging of the lung
(even though they can help to increase the local SNR with-
out parallel imaging) and acceleration factors of R≤2 in
either phase-encode or slice selection/encode directions are
appropriate.
Fig. 5 SSFSE with and without
parallel imaging
Fig. 6 UTE at 1.5 T in a patient with interstitial lung disease
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An important detail of parallel imaging is the method of
coil sensitivity calibration, which is needed to determine the
sensitivity profiles of the coils for image reconstruction. As
the lungs are prone to movement, a method with integrated
or auto-calibration is preferable (e.g. GRAPPA [16], auto-
SENSE, FLEX). A sequence that requires a separate sensi-
tivity scan is potentially prone to artefacts due to spatial mis-
registration of calibration information with imaging data.
Ultra-short echo time (UTE) imaging
Originally proposed by Bergin et al. [19] for lung parenchyma
imaging, ultra-short echo time sequences have recently be-
come available that use radial k-space sampling to shorten the
echo times well below 1 ms. At a TE of 100 μs and less, the
short T2* of lung parenchyma is less of a constraint, and MR
images with parenchymal sensitivity can be acquired. Two-
dimensional UTE sequences [19] require twice the number of
RF pulses in order to achieve slice selection, which doubles
the acquisition time. Furthermore, the T2* decay of the pa-
renchymal signal introduces a k-space filter in the frequency
encode direction (akin to that experienced in the phase encode
direction in SSFSE imaging) which limits the achievable
spatial resolution well below the nominal one. Nevertheless,
UTE imaging shows promise for lung MRI, because a proton
density contrast can be achieved that resembles that of CT.
Furthermore, this pulse sequence enables visualisation of
parenchymal lung disease, which has so far been impossible
with MRI (Fig. 6).
Contrast enhancement
High-quality pulmonary angiograms can be obtained at
breath-hold with injection of T1-shortening contrast agents
such as Gd-DTPA using heavily T1-weighted 3D GRE
sequences [20]. The pulse sequence of choice for high-
resolution 3D pulmonary MRA is a spoiled gradient echo
(FLASH, SPGR, FFE) with the shortest possible TR and TE
and high readout bandwidth. Modest parallel imaging can
improve the spatial resolution for a given breath-hold dura-
tion [21] (Fig. 7).
For an adult patient, the typical imaging parameters for a
coronal 3D data set are: TR02.5-3 ms, TE01.0-1.5 ms, α0
30-40°, matrix: 40×192×256, FOV: 460 mm, parallel im-
aging factor R02. Centric elliptic phase encoding [22], with
the scan acquisition starting at peak enhancement ensures
maximum SNR and optimal separation of arterial and ve-
nous phases. Typical contrast doses used are for example
0.2 mmol/kg body weight Gd-BT-DO3A followed by a 20
ml saline flush injected at 5 ml/s.
The time from injection of the contrast agent to start of
acquisition can be optimised with a time-resolved bolus-
training scan following injection of a 1-ml bolus of contrast
agent. Alternatively, a time-resolved 3D acquisition with
view sharing such as a TRICKS sequence [23] can be used,
which additionally delineates the arterial and venous regional
haemodynamics, regional perfusion defects and cardiac
shunts. With TRICKS, k-space data are shared between suc-
cessive data sets, which leads to minor temporal interpolation
artefacts—thus, TRICKS data should be used with care when
a rapid signal change is observed (as, for example, during
bolus arrival) (Fig. 8).
Quantitative T1-weighted perfusion images can be
obtained by using a time-resolved low spatial resolution
version of the sequences described above. Here, typical
imaging parameters would be: TR02.0-2.5 ms, TE00.8-
1.0 ms, α030-40°, matrix: 32×96×128, FOV: 460 mm.
With a temporal resolution of better than 1 s per 3D
data set this technique allows the generation of contrast
Fig. 8 Time-resolved bolus passage TRICKS data set
Fig. 7 Breath-hold CE pulmonary MRA
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passage kinetics curves and parametric maps of regional
blood flow, volume and transit times. Again, parallel
imaging and view sharing can enhance the temporal
resolution. The contrast agent dose should be less than
is needed for the pulmonary angiogram; for example,
0.05 mmol/kg Gd-BT-DO3A + 20 ml saline flush at
5 ml/s provides robust results in patients with pulmo-
nary vascular disease. If fully quantitative maps of
pulmonary blood volume (PBV), blood flow (PBF)
and transit time (MTT) are sought, a deconvolution
with an arterial input function (AIF) measured in the
larger arteries is required. For this, weaker doses still
may be needed to ensure a linear signal response be-
tween contrast concentration and the signal of the AIF
due to T1-weighting [24] (Fig. 9).
Functional sensitivity of proton lung MRI
The basic pulse sequences outlined above can be further
sensitised to physiological processes. Their signal can be
modulated by respiration, blood flow, and inhalation of
Fig. 10 A series of images acquired during inversion recovery at different inversion times with a Look-Locker sequence and the resulting T1 maps
obtained breathing air and oxygen
Fig. 9 Parametric maps of
perfusion
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oxygen to give functional information. Techniques for func-
tional lung MRI are briefly outlined.
Oxygen-enhanced 1H MRI
When a subject breathes pure oxygen instead of room air,
the paramagnetic oxygen shortens the T1 of the blood,
plasma and tissue in the lungs. This T1-shortening leads to
a signal enhancement, which can be quantified with para-
metric maps with an inherent ventilation and perfusion
weighting. Two strategies for ventilation and perfusion im-
aging have been proposed:
The first technique is semi-quantitative and utilises
an inversion-recovery HASTE sequence. The 2D
HASTE readout uses a short echo time to visualise
the lung parenchyma; however, prior to the data acqui-
sition a non-selective inversion pulse is applied fol-
lowed by an inversion delay TI to impart an
additional T1 contrast on the HASTE image. A global
inversion pulse should be used rather than a slice
selective one to avoid inflow effects of blood with a
different magnetisation history [25]. The TI is chosen
so that the signal from the perfused pulmonary vascu-
lar bed is nulled when breathing room air (at the T1 of
the lung parenchyma 1,100–1,300 ms at 1.5 T [26] ,
TI00.69×T10700–900 ms). Pure oxygen is then ad-
ministered via a tight-fitting face mask, which reduces
the mean T1 of the lung plasma and tissue, and a
signal enhancement is seen in the IR-HASTE images
[27]. The technique is implicitly ventilation- and
perfusion-weighted and thus represents an indirect
way of measuring both aspects of lung function. The
method can be made more quantitative with T1 map-
ping which uses the inversion pulse as IR-HASTE, but
a series of low flip angle FLASH images (Look-Locker
sequence [28]). This allows quantitative inferal of lung
tissue/plasma partial pressure of oxygen (p02) to be
made [29, 30]. A series of Look-Locker images is
shown in Fig. 10, together with the T1 maps of the
lung for both room air and pure oxygen breathing.
An alternative method uses a bSSFP sequence to repeat-
edly acquire images from the same slice [31]. The time
course of the signal is then analysed by Fourier decomposi-
tion giving images which are weighted by lung perfusion at
a frequency of around 1 Hz (the pulse rate) and images
which are weighted at a lower frequency (~0.2 Hz) by
respiratory motion. Thus, ventilation and perfusion-
weighted images can be derived from that slice [32]. To
implement the bSSFP method, high SNR is paramount,
which can be achieved using centric encoding and acquisi-
tion during the transient steady state and a magnetisation flip
back pulse after each acquisition.
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